Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Nilotinib

Nilotinib is a medication used for slowing down the progression of a certain type of cancer known as chronic myeloid leukemia. It is specifically prescribed for people who have not responded to certain other chemotherapy drugs or for those who have been recently diagnosed with this form of leukemia. The capsules are taken twice daily. Side effects may include a rash, itching, and nausea.

What Is Nilotinib?

Nilotinib (Tasigna®) is a prescription medication approved to treat chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. It belongs to a group of medicines known as tyrosine kinase inhibitors. Nilotinib is used in people who are newly diagnosed with leukemia, or those who are no longer benefiting from or cannot tolerate imatinib (Gleevec®), another tyrosine kinase inhibitor medication.
 
(Click What Is Nilotinib Used For? for more information on this topic, including possible off-label uses.)
 

Are There Side Effects?

Just like any medicine, nilotinib can cause side effects. Although not everyone who uses the drug will have problems, most people will experience some type of nilotinib side effect during treatment.
 
If reactions do occur, in most cases, they are mild or moderate in severity and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
 
Common side effects of nilotinib include but are not limited to:
 
 
(Click Nilotinib Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
7 Natural Ways to Reduce Your Cancer Pain

Nilotinib Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.